MapLight Therapeutics (MPLT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
MPLT slides 4.0% to $7.70, a 52-week low. Closed at $7.70, -3.99% vs the prior close of $8.02. Day range $7.56–$8.10, opened at $8.10.
MPLT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MPLT slides 4.0% to $7.70, a 52-week low
- Closed at $7.70, -3.99% vs the prior close of $8.02. Day range $7.56–$8.10, opened at $8.10.
- Volume was 359.06K shares, 0.7x its 50-day average of 526.10K.
- Price is -31.3% vs its 50-day average ($11.21) and -63.3% vs its 200-day average ($20.99).
- 52-week range $7.46–$40.43; today's close sits at 1% of that range, 81.0% below the 52-week high.
Oct 15, 2026 — MPLT rises 2.7% to $8.02
- Closed at $8.02, +2.69% vs the prior close of $7.81. Day range $7.74–$8.43, opened at $7.84.
- Volume was 658.40K shares, 1.2x its 50-day average of 530.67K.
- Price is -29.2% vs its 50-day average ($11.32) and -61.9% vs its 200-day average ($21.04).
- 52-week range $7.46–$40.43; today's close sits at 2% of that range, 80.2% below the 52-week high.
Oct 14, 2026 — MPLT dips 0.8% to $7.81, a 52-week low, 6 down days in a row
- Closed at $7.81, -0.83% vs the prior close of $7.88. Day range $7.46–$8.07, opened at $7.78.
- Volume was 450.90K shares, 0.8x its 50-day average of 538.60K.
- Price is -31.6% vs its 50-day average ($11.42) and -63.0% vs its 200-day average ($21.09).
- 52-week range $7.46–$40.43; today's close sits at 1% of that range, 80.7% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — MPLT slides 8.4% to $7.88, a 52-week low, 5 down days in a row
- Closed at $7.88, -8.43% vs the prior close of $8.60. Day range $7.85–$8.60, opened at $8.60.
- Volume was 301.70K shares, 0.5x its 50-day average of 552.57K — lighter than usual.
- Price is -31.6% vs its 50-day average ($11.52) and -62.8% vs its 200-day average ($21.14).
- 52-week range $7.85–$40.43; today's close sits at 0% of that range, 80.5% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — MPLT dips 2.6% to $8.60, a 52-week low, 4 down days in a row
- Closed at $8.60, -2.60% vs the prior close of $8.83. Day range $8.48–$8.90, opened at $8.82.
- Volume was 485.20K shares, 0.9x its 50-day average of 565.85K.
- Price is -26.0% vs its 50-day average ($11.61) and -59.4% vs its 200-day average ($21.20).
- 52-week range $8.48–$40.43; today's close sits at 0% of that range, 78.7% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — MPLT slides 3.5% to $8.83, a 52-week low, 3 down days in a row
- Closed at $8.83, -3.50% vs the prior close of $9.15. Day range $8.70–$9.41, opened at $9.15.
- Volume was 495.40K shares, 0.8x its 50-day average of 618.99K.
- Price is -24.6% vs its 50-day average ($11.70) and -58.4% vs its 200-day average ($21.24).
- 52-week range $8.70–$40.43; today's close sits at 0% of that range, 78.2% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — MPLT dips 2.2% to $9.15, a 52-week low
- Closed at $9.15, -2.24% vs the prior close of $9.36. Day range $9.00–$9.33, opened at $9.30.
- Volume was 217.60K shares, 0.3x its 50-day average of 676.43K — lighter than usual.
- Price is -22.5% vs its 50-day average ($11.81) and -57.0% vs its 200-day average ($21.29).
- 52-week range $8.92–$40.43; today's close sits at 1% of that range, 77.4% below the 52-week high.
Oct 7, 2026 — MPLT slides 3.4% to $9.36
- Closed at $9.36, -3.41% vs the prior close of $9.69. Day range $9.30–$9.88, opened at $9.62.
- Volume was 275.20K shares, 0.4x its 50-day average of 781.73K — lighter than usual.
- Price is -21.5% vs its 50-day average ($11.92) and -56.2% vs its 200-day average ($21.35).
- 52-week range $8.92–$40.43; today's close sits at 1% of that range, 76.8% below the 52-week high.
Oct 6, 2026 — MPLT jumps 4.5% to $9.69
- Closed at $9.69, +4.47% vs the prior close of $9.27. Day range $8.92–$9.97, opened at $9.24.
- Volume was 495.60K shares, 0.5x its 50-day average of 934.78K — lighter than usual.
- Price is -19.1% vs its 50-day average ($11.98) and -54.7% vs its 200-day average ($21.40).
- 52-week range $8.92–$40.43; today's close sits at 2% of that range, 76.0% below the 52-week high.
Oct 5, 2026 — MPLT slides 5.5% to $9.27, a 52-week low
- Closed at $9.27, -5.55% vs the prior close of $9.82. Day range $9.19–$9.80, opened at $9.80.
- Volume was 262.00K shares, 0.3x its 50-day average of 940.49K — lighter than usual.
- Price is -22.6% vs its 50-day average ($11.99) and -56.8% vs its 200-day average ($21.45).
- 52-week range $9.10–$40.43; today's close sits at 1% of that range, 77.1% below the 52-week high.
Oct 2, 2026 — MPLT rises 2.0% to $9.82
- Closed at $9.82, +1.97% vs the prior close of $9.63. Day range $9.43–$10.17, opened at $9.70.
- Volume was 565.70K shares, 0.6x its 50-day average of 936.70K.
- Price is -21.7% vs its 50-day average ($12.53) and -54.3% vs its 200-day average ($21.51).
- 52-week range $9.10–$40.43; today's close sits at 2% of that range, 75.7% below the 52-week high.
MPLT latest news & SEC filings
Every SEC filing by or about MPLT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kreitzer Anatol sold 12,248 shares at $7.84 (≈$96.02K) on Oct 15, 2026; now holds 168,678
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gillis Jonathan sold 10,167 shares at $8.08 (≈$82.15K) on Oct 15, 2026; now holds 142,315
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lillie James Woodruff sold 11,513 shares at $8.08 (≈$93.03K) on Oct 15, 2026; now holds 198,597
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hanson Kristopher sold 9,020 shares at $8.08 (≈$72.88K) on Oct 15, 2026; now holds 128,024
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Foff Erin Pennock sold 15,355 shares at $8.08 (≈$124.07K) on Oct 15, 2026; now holds 296,906
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kroeger Christopher A. sold 73,691 shares at $8.08 (≈$595.42K) on Oct 15, 2026; now holds 1,195,909
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 23, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 23, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 18, 2026 · Form S-1/A — S-1/A filing
S-1/A filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 9, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 20, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 18, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$60.19M (prior year -$29.84M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.32 (prior year -$39.11) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.02 — Reported results of operations (earnings release).
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 3, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade MPLT
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 26, 2026, Jan 9, 2026. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.64% (largest 8.4%).
- Liquidity: about 405.73K shares (≈$3.12M) trade per day on average.
- 52-week position: $7.70 vs a range of $7.46–$40.43 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 17 open-market buys, 8 sales; latest: Kristopher Hanson sold 16,509 shares on Sep 16, 2026.
- Latest filings: 10-Q Aug 13, 2026; 8-K Aug 13, 2026; 8-K Jul 27, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MPLT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 8.10 | 8.10 | 7.56 | 7.70 | 359.06K |
| Oct 15, 2026 | 7.84 | 8.43 | 7.74 | 8.02 | 658.40K |
| Oct 14, 2026 | 7.78 | 8.07 | 7.46 | 7.81 | 450.90K |
| Oct 13, 2026 | 8.60 | 8.60 | 7.85 | 7.88 | 301.70K |
| Oct 12, 2026 | 8.82 | 8.90 | 8.48 | 8.60 | 485.20K |
| Oct 9, 2026 | 9.15 | 9.41 | 8.70 | 8.83 | 495.40K |
| Oct 8, 2026 | 9.30 | 9.33 | 9.00 | 9.15 | 217.60K |
| Oct 7, 2026 | 9.62 | 9.88 | 9.30 | 9.36 | 275.20K |
| Oct 6, 2026 | 9.24 | 9.97 | 8.92 | 9.69 | 495.60K |
| Oct 5, 2026 | 9.80 | 9.80 | 9.19 | 9.27 | 262.00K |
| Oct 2, 2026 | 9.70 | 10.17 | 9.43 | 9.82 | 565.70K |
| Oct 1, 2026 | 10.16 | 10.16 | 9.57 | 9.63 | 432.20K |
| Sep 30, 2026 | 10.45 | 10.51 | 9.93 | 10.19 | 303.30K |
| Sep 29, 2026 | 10.64 | 10.64 | 10.12 | 10.15 | 408.30K |
| Sep 28, 2026 | 10.39 | 10.59 | 10.15 | 10.45 | 251.60K |
| Sep 25, 2026 | 10.81 | 10.87 | 10.39 | 10.46 | 317.50K |
| Sep 24, 2026 | 10.60 | 10.86 | 10.16 | 10.76 | 341.80K |
| Sep 23, 2026 | 10.89 | 10.93 | 10.13 | 10.77 | 539.00K |
| Sep 22, 2026 | 11.02 | 11.28 | 10.64 | 10.86 | 411.30K |
| Sep 21, 2026 | 11.06 | 11.28 | 10.78 | 10.90 | 542.90K |
About MapLight Therapeutics
MapLight Therapeutics (MPLT) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in REDWOOD CITY, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1770069.
MPLT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Martin Babler | Director | Jun 25, 2026 |
| Troy Cox | Director | Jul 28, 2026 |
| Timothy John Garnett | Director | Jun 25, 2026 |
| Christopher A. Kroeger | Chief Executive Officer | Aug 19, 2026 |
| Nanna Liebach Luneborg | Director | Jun 25, 2026 |
| Robert C. Malenka | Director | Apr 17, 2026 |
| George Pavlov | Director | Jun 25, 2026 |
| James D. Trenkle | Director | Oct 27, 2025 |
| Maria C Walker | Director | Jun 25, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Erin Pennock Foff | Chief Medical Officer | Aug 19, 2026 |
| Jonathan Gillis | CAO and Interim CFO | Aug 19, 2026 |
| Kristopher Hanson | General Counsel | Sep 18, 2026 |
| Anatol Kreitzer | Chief Discovery Officer | Aug 19, 2026 |
| Christopher A. Kroeger | Chief Executive Officer | Aug 19, 2026 |
| James Woodruff Lillie | Chief Scientific Officer | Aug 19, 2026 |
| Vishwas Setia | Chief Financial Officer | May 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 16, 2026 | Kristopher Hanson | Sale | 16,509 | $11.67 |
| Sep 16, 2026 | Kristopher Hanson | Sale | 16,509 | $11.67 |
| Sep 16, 2026 | Kristopher Hanson | Sale | 16,509 | $11.67 |
| Sep 16, 2026 | Kristopher Hanson | Sale | 16,509 | $11.67 |
| Aug 14, 2026 | Inc. Catalyst4, | Buy | 4,400,000 | $11.38 |
| Aug 14, 2026 | Inc. Catalyst4, | Buy | 4,400,000 | $11.38 |
| Aug 14, 2026 | Inc. Catalyst4, | Buy | 4,400,000 | $11.38 |
| Aug 14, 2026 | Inc. Catalyst4, | Buy | 4,400,000 | $11.38 |
| Aug 3, 2026 | James Woodruff Lillie | Sale | 22,082 | $12.54 |
| Aug 3, 2026 | James Woodruff Lillie | Sale | 22,082 | $12.54 |
| Aug 3, 2026 | James Woodruff Lillie | Sale | 22,082 | $12.54 |
| Aug 3, 2026 | James Woodruff Lillie | Sale | 22,082 | $12.54 |
| Jul 30, 2026 | Inc. Catalyst4, | Buy | 1,000,000 | $13.00 |
| Jul 30, 2026 | Inc. Catalyst4, | Buy | 1,000,000 | $13.00 |
| Jul 30, 2026 | Inc. Catalyst4, | Buy | 1,000,000 | $13.00 |
MPLT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-161.15M | -18.56 | $-138.14M |
| Dec 31, 2024 | — | $-77.58M | -105.38 | $-78.81M |
Latest balance sheet: total assets $368.35M, total liabilities $20.05M, cash $71.63M (as of Jun 30, 2026).
MPLT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $11.58 |
| May 14, 2026 | 8-K Item 2.02 (results) | $29.29 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $19.23 |
| Jan 9, 2026 | 8-K Item 2.02 (results) | $18.02 |
| Dec 4, 2025 | 8-K Item 2.02 (results) | $18.34 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MPLT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.